Works matching IS 2160763X AND DT 2017 AND VI 6 AND IP 3
Results: 13
A Randomized Phase 1 Study to Assess the Safety and Pharmacokinetics of the Subcutaneously Injected Anti-LIGHT Antibody, SAR252067.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 292, doi. 10.1002/cpdd.295
- By:
- Publication type:
- Article
Analgesic Efficacy of a New Immediate-Release/Extended-Release Formulation of Ibuprofen: Results From Single- and Multiple-Dose Postsurgical Dental Pain Studies.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 302, doi. 10.1002/cpdd.297
- By:
- Publication type:
- Article
Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 280, doi. 10.1002/cpdd.298
- By:
- Publication type:
- Article
Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 266, doi. 10.1002/cpdd.299
- By:
- Publication type:
- Article
Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 246, doi. 10.1002/cpdd.287
- By:
- Publication type:
- Article
Dose-Dependent Effect of Piragliatin, a Glucokinase Activator, on the QT Interval Following Short-Term Multiple Doses in Patients With Type 2 Diabetes Mellitus.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 258, doi. 10.1002/cpdd.289
- By:
- Publication type:
- Article
Some Thoughts About the Mean Concentration-Versus-Time Plot.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 220, doi. 10.1002/cpdd.353
- By:
- Publication type:
- Article
The Journal of Clinical Pharmacology, Clinical Pharmacology in Drug Development, and the Impact Factor.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 213, doi. 10.1002/cpdd.302
- Publication type:
- Article
Clinical Experience With Desvenlafaxine in Treatment of Patients With Fibromyalgia Syndrome.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 224, doi. 10.1002/cpdd.271
- By:
- Publication type:
- Article
Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50-mg Film-Coated Tablet.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 313, doi. 10.1002/cpdd.275
- By:
- Publication type:
- Article
Methotrexate Polyglutamate Monitoring in Patients With Crohn's Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 240, doi. 10.1002/cpdd.279
- By:
- Publication type:
- Article
A Comparative Pharmacokinetic Study of 2 Pemetrexed Formulations in Indian Adult Chemonaive Patients With Adenocarcinoma Stage III/IV Non-Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 3, p. 234, doi. 10.1002/cpdd.347
- By:
- Publication type:
- Article